跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CLINDAMYCIN INJECTION IN 5% DEXTROSE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CLINDAMYCIN INJECTION IN 5% DEXTROSE
Authorized
STANDARD
CLINDAMYCIN INJECTION IN 5% DEXTROSE
baxter corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
40b150ece8df45e3
Company
baxter corporation
Type
Standard
Approval Details
Approval Id
40b150ece8df45e3
Drug Approval Canada Name
CLINDAMYCIN INJECTION IN 5% DEXTROSE
Product Name
CLINDAMYCIN INJECTION IN 5% DEXTROSE
Status
Marketed
Status Date
2019-11-26
Original Market Date
2019-11-26
Din
02485478
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
08:12.28.20
Atc Original
J01FF01 CLINDAMYCIN
Atc Name
j 01 ff 01
Aig Number
0105830009
Company Name
baxter corporation
Company Address
7125 Mississauga Road, Mississauga, Ontario, Canada, L5N 0C2
Active Ingredients
CLINDAMYCIN (CLINDAMYCIN PHOSPHATE)
600 MG / 50 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
40b150ece8df45e3
Type
Standard
Back to Health Canada Approvals